Hot Safest Companies To Invest In 2014

As Jeff Clark expected would happen in late June, gold stocks have put in a bottom... and staged a huge rally.   The benchmark gold index is up 36% off its lows.   Like Jeff, I expect gold stocks will work higher over the longer-term. Of course, there will be corrections along the way, which is why you should stick to some of the world's safest gold stocks.   The key to safety is to focus on "all-in" costs. This is the total cost of an ounce of gold production. It includes the cost of mining at each mine the company owns, plus the costs of running the company.   It is a way to look at gold-mining companies as businesses, instead of simply a way to play rising gold prices. It's a critical idea for making money in the gold-stock sector...   In my most recent issue of the S&A Resource Report, I presented a proprietary, in-depth analysis of the gold sector. I showed readers a selection of the best companies from the gold sector with our estimated "all-in" costs.

10 Best Telecom Stocks For 2015: Coronado Biosciences Inc (CNDO)

Coronado Biosciences, Inc., incorporated on June 28, 2006, is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company�� two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn�� disease (Crohn��), ulcerative colitis (UC) and multiple sclerosis (MS), and CNDO-109, a compound that activates natural killer (NK) cells of the immune system to seek and destroy cancer cells, for the treatment of acute myeloid leukemia (AML). In January 2011, the Company acquired the OvaMed GmbH License.

TSO

TSO is the microscopic eggs of a parasitic helminth, or worm, that is found in pigs. In September 2011, the Company filed an Investigational New Drug Application (IND) with the United States Food and Drug Administration (FDA) and it initiated a single dose, dose escalation study in patients with Crohn�� in February 2012. The Phase 1 clinical trial was a multi-center, sequential dose-escalation, double-blind, placebo-controlled study, the primary objective of which was to evaluate the safety and tolerability of TSO. The trial enrolled 36 patients with Crohn�� ranging in age from 20 to 54 with an equal distribution of male and female patients in three single dose cohorts of orally administered 500, 2500 and 7500 ova. Each cohort had 12 patients, with nine patients receiving TSO and three receiving placebo.

CNDO-109

CNDO-109 is a lysate (disrupted CTV-1 cells, cell membrane fragments, cell proteins and other cellular components) that activates donor NK cells. CTV-1 is a leukemic cell line recently re-classified as a T-cell acute lymphocytic leukemia (ALL). The Company has worldwide rights to develop and commercialize CNDO-109 activated NK cells for the treatment of cancer fro! m UCLB. In February 2012, the Company submitted an IND for the CNDO-109 activated NK cell product in the United States. The treatment of patients with CNDO-109 activated NK cells involves several steps. The activated NK cells are infused into the patient after resting NK cells are incubated with CNDO-109 for at least eight hours. Preparation of CNDO-109 activated NK cells takes about 24 hours from start to finish.

The Company competes with Centocor Ortho Biotech Inc.�� Remicade , UCB S.A.�� Cimzia, Abbott Laboratories��Humira, Biogen Idec�� Avonex, Bayer Healthcare Pharmaceuticals��Betaseron, Teva Pharmaceuticals Industries, Ltd.�� Copaxone and Novartis AG�� Gilenya.

Advisors' Opinion:

• [By Roberto Pedone]

  Coronado Biosciences (CNDO), a clinical stage biopharmaceutical company, focuses on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. This stock closed up 2.7% to $9.13 in Tuesday's trading session.

  Tuesday's Range: $8.85-$9.58
  
  52-Week Range: $4.00-$12.70
  
  Tuesday's Volume: 1.31 million
  
  Three-Month Average Volume: 419,038

  From a technical perspective, CNDO trended up here right above some near-term support at $8.79 with heavy upside volume. This move is starting to push shares of CNDO within range of triggering a near-term breakout trade. That trade will hit if CNDO manages to take out some near-term overhead resistance levels at $9.60 to $10.20 and then once it takes out more resistance at $10.35 with high volume.

  Traders should now look for long-biased trades in CNDO as long as it's trending above its 50-day at $8.52 and then once it sustains a move or close above those breakout levels with volume that hits near or above 419,038 shares. If that breakout hits soon, then CNDO will set up to re-test or possibly take out its next major overhead resistance levels at $11 to $11.81. Any high-volume move above those levels will then put its all-time high at $12.70 into range for shares of CNDO.

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company Coronado Biosciences (NASDAQ: CNDO  ) has received a distressing two-star ranking.

• [By Roberto Pedone]

  Coronado Biosciences (CNDO) is a biopharmaceutical company focused on novel immunotherapy biologic agents for autoimmune diseases and cancer. This stock closed up 4.9% to $8.22 in Thursday's trading session.

  Thursday's Range: $7.84-$8.29
  
  52-Week Range: $4.00-$12.70
  
  Thursday's Volume: 323,000
  
  Three-Month Average Volume: 390,192

  From a technical perspective, CNDO spiked higher here right above its 200-day moving average of $7.63 with decent upside volume. This stock has been downtrending badly for the last three months, with shares falling from its high of $12.70 to its recent low of $7.32. During that move, shares of CNDO have been consistently making lower highs and lower lows, which is bearish technical price action. Shares of CNDO now look ready to reverse that trend and potentially trigger a near-term breakout trade. That trade will hit if CNDO manages to take out some near-term overhead resistance levels at $8.56 to $8.94 with high volume.

  Traders should now look for long-biased trades in CNDO as long as it's trending above its 200-day at $7.63 or above more support at $7.32 and then once it sustains a move or close above those breakout levels with volume that hits near or above 390,192 shares. If that breakout hits soon, then CNDO will set up to re-test or possibly take out its next major overhead resistance levels at $9.50 to $10.35. Any high-volume move above those levels will then put its next major resistance level at $11 into range for shares of CNDO.

Hot Safest Companies To Invest In 2014: Cbeyond Inc.(CBEY)

Cbeyond, Inc. provides managed information technology (IT) and communications services to small businesses in the United States. Its services include local and long-distance voice, broadband Internet, mobile services, broadband laptop access, voicemail, email, Web hosting, fax-to-email, data backup, file-sharing, virtual private networking, and cloud servers; and cloud applications, data center infrastructure as a service, cloud private branch exchange phone systems, metro Ethernet, multi-protocol label switching, information security, administration management, and professional services to migrate and manage customer environments. It sells its products and services through direct sales; value-added resellers, local area network consultants, and other IT and communications consultants; and managed services providers, systems integrators, and software vendors. The company was formerly known as Cbeyond Communications, Inc. and changed its name to Cbeyond, Inc. in July 2006. Cbeyond, Inc. was founded in 2000 and is headquartered in Atlanta, Georgia.

Advisors' Opinion:

• [By Monica Gerson]

  Cbeyond (NASDAQ: CBEY) soared 6.29% to $6.76 in the pre-market trading. Cbeyond shares have dropped 10.67% over the past 52 weeks, while the S&P 500 index has gained 26.42% in the same period.

• [By Lisa Levin]

  Cbeyond (NASDAQ: CBEY) shares gained 38.56% to touch a new 52-week high of $9.81 after the company agreed to be acquired by Birch Communications in all-cash transaction valued at $323 million.

Hot Safest Companies To Invest In 2014: Canterbury Park Holding Corporation(CPHC)

Canterbury Park Holding Corporation conducts pari-mutuel wagering operations and hosts unbanked card games at its Canterbury Park racetrack and card room facility in Shakopee, Minnesota. The company operates in three segments: Horse Racing, Card Room, and Concessions. The Horse Racing segment operates year-round pari-mutuel wagering on simulcast horse races, and live thoroughbred and quarter horse races held on a seasonal basis. The Card Room segment offers unbanked card games, which include poker and casino games. The Concessions segment provides food and beverage services for simulcast and live racing, and the card room, as well as for the special events. The company also offers facilities for special events, such as snowmobile races, arts and crafts shows, trade shows, concerts, fundraisers, automobile shows and competitions, vehicle and boat storage, and private parties. In addition, it provides advertising signage space; leases excess parking lot space for various aut omotive activities and vehicle storage; and sells various daily pari-mutuel publications. Canterbury Park Holding Corporation was founded in 1994 and is based in Shakopee, Minnesota.

Advisors' Opinion:

• [By Monica Wolfe]

  Lastly, Gabelli increased his position in Canterbury Park Holding (CPHC). Gabelli upped his stake 3.18% by purchasing a total of 13,824 shares. He bought these shares at an average price of $11.11 per share, and since then the price per share is up about 3%. Gabelli now holds 447,944 shares, representing 10.74% of the company�� shares outstanding.

• [By Sally Jones]

  Canterbury Park Holding Corporation (CPHC) ��Market Cap $46.35 Million

  Canterbury Park Holding Corporation is up 2% over 12 months. The company has a market cap of $46.35 million; its trades around $11.16 with a P/E ratio of 59.30 and a P/B of 1.70.

Hot Safest Companies To Invest In 2014: Athersys Inc.(ATHX)

Athersys, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic products in various disease areas in the United States. Its clinical development programs are focused on treating cardiovascular disease, neurological conditions, inflammatory and immune disorders, and other conditions. Its product pipeline includes MultiStem, a novel allogeneic approach to stem cell therapy and regenerative medicine for treating a range of diseases. The company is also involved in the development of novel small molecule compounds for applications in indications, such as obesity and other areas, including the treatment of neurological conditions, and for the modulation of stem cells or related applications in the regenerative medicine area. It has product co-development collaboration with Pfizer Inc. to develop and commercialize MultiStem to treat inflammatory bowel disease for the worldwide market; Angiotech Pharmaceuticals, Inc. to develop and commerciali ze MultiStem to treat certain cardiovascular diseases, such as acute myocardial infarction; and RTI Biologics, Inc. to develop and commercialize biologic implants for certain orthopedic applications in the bone graft substitutes market. The company was founded in 1995 and is based in Cleveland, Ohio.

Advisors' Opinion:

• [By Roberto Pedone]

  Athersys (ATHX), a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. This stock closed up 2.5% to $1.59 in Thursday's trading session.

  Thursday's Range: $1.53-$1.59
  
  52-Week Range: $1.08-$4.33
  
  Thursday's Volume: 128,000
  
  Three-Month Average Volume: 416,142

  From a technical perspective, ATHX bounced notably higher here right above some near-term support levels at $1.53 to $1.49 with lighter-than-average volume. This stock has been trending sideways and consolidating for the last two months, with shares moving between $1.49 on the downside and $1.99 on the upside. This spike higher on Thursday is starting to push shares of ATHX within range of triggering a near-term breakout trade. That trade will hit if ATHX manages to take out Thursday's intraday high of $1.59 to its 50-day moving average of $1.65 with high volume.

  Traders should now look for long-biased trades in ATHX as long as it's trending above some key near-term support at $1.49 and then once it sustains a move or close above those breakout levels with volume that hits near or above 416,142 shares. If that breakout kicks off soon, then ATHX will set up to re-test or possibly take out its next major overhead resistance levels at $1.70 to $1.73, or even $1.78. Any high-volume move above $1.78 will then give ATHX a chance to re-test or possibly take out the upper-end of its recent range at $1.99.

Hot Safest Companies To Invest In 2014: Ocado Group PLC (OCDO)

Ocado Group plc is a United Kingdom-based holding company. The Company�� principal activities are the retailing, logistics and distribution of grocery and consumer goods and the development and monetisation of intellectual property and technology for the online retailing, logistics and distribution of these goods. The Company is an online grocery retailer. The Company�� subsidiaries include Ocado Holdings Limited, Ocado Limited, Ocado Information Technology Limited, Last Mile Developments Limited and Last Mile Developments Limited. Advisors' Opinion:

• [By Sarah Jones]

  Rio Tinto Group and Anglo American Plc (AAL) retreated more than 2.5 percent as copper and lead declined. Eurasian Natural Resources Corp. (ENRC) sank 6.8 percent as analysts downgraded the shares. Standard Life Plc slipped 1.2 percent as Chief Financial Officer Jackie Hunt resigned to move to a rival insurer. Ocado Group Plc (OCDO) fell for the first day this week as the online grocer ruled out a takeover by William Morrison Supermarkets Plc.